Genetic tests: a search for economy of scale.
作者信息
Hillner B
出版信息
Am J Hum Genet. 1996 Aug;59(2):287-8.
Abstract
摘要
相似文献
1
Genetic tests: a search for economy of scale.基因检测：寻求规模经济
Am J Hum Genet. 1996 Aug;59(2):287-8.
2
Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma.视网膜母细胞瘤高危亲属分子筛查与传统筛查的成本比较
Am J Hum Genet. 1996 Aug;59(2):301-7.
3
A stepwise strategy for rapid and cost-effective RB1 screening in Indian retinoblastoma patients.印度视网膜母细胞瘤患者快速且经济高效的RB1筛查的逐步策略。
J Hum Genet. 2015 Sep;60(9):547-52. doi: 10.1038/jhg.2015.62. Epub 2015 Jun 18.
4
Retinoblastoma: genetic testing versus conventional clinical screening in India.视网膜母细胞瘤：印度的基因检测与传统临床筛查
Mol Diagn. 2004;8(4):237-43. doi: 10.1007/BF03260068.
5
Critical factors in the performance and cost of two-dimensional gene scanning: RB1 as a model.二维基因扫描性能和成本的关键因素：以RB1基因为例
Biotechniques. 1998 Oct;25(4):664-8, 670, 672-5. doi: 10.2144/98254dt06.
6
Genetic testing in Tunisian families with heritable retinoblastoma using a low cost approach permits accurate risk prediction in relatives and reveals incomplete penetrance in adults.采用低成本方法对突尼斯患有遗传性视网膜母细胞瘤的家庭进行基因检测，能够准确预测亲属的患病风险，并揭示成年人的不完全外显率。
Exp Eye Res. 2014 Jul;124:48-55. doi: 10.1016/j.exer.2014.04.013. Epub 2014 May 5.
7
Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay.基于人群的研究，旨在确定使用 21 基因检测的医疗系统成本。
J Clin Oncol. 2018 Jan 20;36(3):238-243. doi: 10.1200/JCO.2017.74.2577. Epub 2017 Dec 1.
8
[Genetic approaches to early diagnosis and prevention of retinoblastoma].[视网膜母细胞瘤早期诊断与预防的遗传学方法]
Vopr Onkol. 2000;46(4):490-3.
9
Another liveborn after preimplantation genetic diagnosis for retinoblastoma.
Am J Ophthalmol. 2004 Dec;138(6):1088-9. doi: 10.1016/j.ajo.2004.07.048.
10
What is the value for money of prenatal carrier screening for spinal muscular atrophy? Too soon to say.脊髓性肌萎缩症产前携带者筛查的性价比如何？现在还很难说。
Am J Obstet Gynecol. 2010 Mar;202(3):209-11. doi: 10.1016/j.ajog.2010.01.031.
引用本文的文献
1
The perceived advantages and disadvantages of presymptomatic testing for Machado-Joseph disease: development of a new self-response inventory.Machado-Joseph病症状前检测的感知优势与劣势：一种新型自我反应量表的编制
J Genet Couns. 2006 Oct;15(5):375-91. doi: 10.1007/s10897-006-9033-8. Epub 2006 Sep 27.
本文引用的文献
1
Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma.视网膜母细胞瘤高危亲属分子筛查与传统筛查的成本比较
Am J Hum Genet. 1996 Aug;59(2):301-7.
2
NCI plans national cancer genetics network.
J Natl Cancer Inst. 1996 May 1;88(9):579-80. doi: 10.1093/jnci/88.9.579.
3
Cost effectiveness of antenatal screening for cystic fibrosis.囊性纤维化产前筛查的成本效益
BMJ. 1995 Dec 2;311(7018):1460-3; discussion 1463-4. doi: 10.1136/bmj.311.7018.1460.
4
Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.癌症治疗的疗效与成本效益：基于决策分析的资源合理分配
J Natl Cancer Inst. 1993 Sep 15;85(18):1460-74. doi: 10.1093/jnci/85.18.1460.
5
Coverage of genetic technologies under national health reform.国家医疗改革对基因技术的覆盖范围。
Am J Hum Genet. 1994 Nov;55(5):1054-60.
6
The cost-effectiveness of prenatal carrier screening for cystic fibrosis.囊性纤维化产前携带者筛查的成本效益
Obstet Gynecol. 1994 Dec;84(6):903-12.
7
Decision analysis.决策分析
N Engl J Med. 1987 Jan 29;316(5):250-8. doi: 10.1056/NEJM198701293160505.
Zotero 插件